Aquatic Capital Management LLC Halozyme Therapeutics, Inc. Transaction History
Aquatic Capital Management LLC
- $2.69 Billion
- Q2 2024
A detailed history of Aquatic Capital Management LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Aquatic Capital Management LLC holds 16,900 shares of HALO stock, worth $990,509. This represents 0.03% of its overall portfolio holdings.
Number of Shares
16,900
Previous 38,800
56.44%
Holding current value
$990,509
Previous $1.58 Million
43.98%
% of portfolio
0.03%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding HALO
# of Institutions
531Shares Held
122MCall Options Held
199KPut Options Held
77.1K-
Black Rock Inc. New York, NY17.6MShares$1.03 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$756 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$389 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$238 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$200 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.16B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...